The efficacy of this approach is supported by the observation that a WTp53 peptide induced a p53-specific cytotoxic T-cell response against mutp53/WTp53 in both mice [160,161] and in cancer patients [159,162,163,164]. This evidence concerns the gene TP53 and cancer.